Physician profile
William Bauer
NPI 1316931942
$9,008.72
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,480 · 2020: $255 · 2021: $160 · 2022: $114.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $6,691.05 | 2019-2020 | |
| Genzyme Corporation | $431.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $231.17 | 2019 | |
| Collegium Pharmaceutical, INC. | $194.21 | 2019 | |
| Supernus Pharmaceuticals, INC. | $173.17 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $145.12 | 2019 | |
| Genentech USA, INC. | $133.59 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $126.17 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $124.87 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $124.80 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $113.86 | 2022 | |
| Jazz Pharmaceuticals INC. | $99.88 | 2020 | |
| Ucb, INC. | $77.16 | 2019 | |
| Alexion Pharmaceuticals, INC. | $51.86 | 2019 | |
| Acorda Therapeutics, INC | $47.81 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $42.40 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.44 | 2019 | |
| Abbvie INC. | $34.90 | 2021 | |
| Emd Serono, INC. | $21.02 | 2019 | |
| Ge Healthcare | $20.28 | 2019 | |
| Scilex Pharmaceuticals INC. | $19.85 | 2019 | |
| Neurocrine Biosciences, INC. | $19.73 | 2019 | |
| Greenwich Biosciences, INC. | $19.29 | 2019 | |
| Lundbeck LLC | $17.65 | 2019 | |
| Allergan, INC. | $11.45 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.